|
Volumn 21, Issue SUPPL. 3, 2001, Pages
|
In vitro superiority of dual-chambered peritoneal dialysis solution with possible clinical benefits
a a a a a a |
Author keywords
Advanced glycosylation end products; Biocompatibility; Dual chambered peritoneal dialysis fluid; Glucose degradation products
|
Indexed keywords
3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE;
5 HYDROXYMETHYLFURFURAL;
ACETALDEHYDE;
ADVANCED GLYCATION END PRODUCT;
BIC 20;
CAPD 2;
CAPD 2 STAY SAFE BALANCE;
CAPD 3;
CAPD 3 STAY SAFE BALANCE;
CAPD STAY SAFE BALANCE;
FIBRONECTIN;
FORMALDEHYDE;
FURFURAL;
GLUCOSE;
GLUCOSE DEGRADATION PRODUCT;
GLYOXAL;
HUMAN SERUM ALBUMIN;
INTERLEUKIN 1BETA;
INTERLEUKIN 6;
LACTATE DEHYDROGENASE;
LACTIC ACID;
METHYLGLYOXAL;
PERITONEAL DIALYSIS FLUID;
ANIMAL CELL;
ARTICLE;
BIOCOMPATIBILITY;
CELL CULTURE;
CELL DAMAGE;
CELL FUNCTION;
CELL PROLIFERATION;
CELL VIABILITY;
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;
CONTROLLED STUDY;
CYTOKINE RELEASE;
ENZYME RELEASE;
EXPOSURE;
FIBROBLAST;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
INCUBATION TIME;
LONG TERM CARE;
MESOTHELIUM CELL;
MOUSE;
NONHUMAN;
PACKAGING MATERIAL;
PERITONEUM;
PERITONEUM CELL;
PH;
PRIORITY JOURNAL;
ULTRAFILTRATION;
|
EID: 0035568829
PISSN: 08968608
EISSN: None
Source Type: Journal
DOI: 10.1177/089686080102103s16 Document Type: Article |
Times cited : (13)
|
References (27)
|